Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...

We would like to acknowledge the support of the six hundred people listed below who have made donations to the Alameda Post or joined our community as members in the last 12 months. Grants, sponsors, ...

ABI-1179 was contributed by Gilead Sciences (NASDAQ:GILD) under the ongoing collaboration between Assembly Bio and Gilead. The study demonstrated strong potential in the Phase 1a trial conducted ...

Gilead Sciences, Inc. announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly injectable HIV-1 ...

Has Gilead Sciences (GILD) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out. Gilead Sciences is a member of the Medical sector.

Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives ...

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to ...

--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--#GILD--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: TD Cowen Annual Health ...

16 analysts have shared their evaluations of Gilead Sciences GILD during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed view of ...

FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a prominent biotechnology company with a market capitalization of $129.7 billion and impressive 78% gross profit margins, has announced ...